Related references
Note: Only part of the references are listed.A Clinical Nomogram for Predicting Node-positive Disease in Esophageal Cancer
Tara R. Semenkovich et al.
ANNALS OF SURGERY (2021)
External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy
Romain Diamand et al.
EUROPEAN UROLOGY (2021)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
Kohei Shitara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Nomogram Based on Aspartate Aminotransferase/Alanine Aminotransferase (AST/ALT) Ratio to Predict Prognosis After Surgery in Gastric Cancer Patients
Linfang Li et al.
CANCER CONTROL (2020)
Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy
Xuechao Liu et al.
CLINICAL NUTRITION (2019)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
Katrin M. Sjoquist et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
Katrin M. Sjoquist et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Precision medicine in the adjuvant treatment of gastric cancer
Valentina Gambardella et al.
LANCET ONCOLOGY (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals
Shu-Qi Li et al.
CANCER MEDICINE (2018)
Gastric cancer: epidemiology, prevention, classification, and treatment
Robert Sitarz et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy
Qiu-Fang Gao et al.
CANCER CELL INTERNATIONAL (2018)
Clinical Value of Nutritional Status in Cancer: What is its Impact and how it Affects Disease Progression and Prognosis?
Maria Mantzorou et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2017)
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
Yu-ying Lei et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer
Yuming Jiang et al.
JAMA SURGERY (2017)
Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine
Diana Shinko et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
V. P. Jagadesham et al.
BRITISH JOURNAL OF SURGERY (2017)
Postoperative Systemic Inflammatory Response, Complication Severity, and Survival Following Surgery for Colorectal Cancer
Stephen T. McSorley et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer
Jing-lei Qu et al.
PLOS ONE (2015)
Tumors: Wounds That Do Not Heal-Redux
Harold F. Dvorak
CANCER IMMUNOLOGY RESEARCH (2015)
Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study
Esra Kaytan Saglam et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
J. Aparicio et al.
ANNALS OF ONCOLOGY (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer
Graeme J. K. Guthrie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Nomogram Predicting Long-Term Survival After D2 Gastrectomy for Gastric Cancer
Dong-Seok Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis
Hai-Zhen Dang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Okines et al.
ANNALS OF ONCOLOGY (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
HER-2/neu amplification is an independent prognostic factor in gastric cancer
Dong Il Park et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
